News - Amorchem

August 12, 2021 AmorChem invests in novel approach to target Myc-driven cancers Read article

August 12, 2021 AmorChem invests in a new gene therapy approach to help patients with a devastating orphan disease Read article

August 12, 2021 Consortium Backs Netherton Syndrome Project From Sinai Health Read article

August 12, 2021 AmorChem invests in the work of Sidong Huang at McGill University Read article

August 12, 2021 AmorChem invests in a potential treatment for cerebral amyloid angiopathy and Alzheimer’s disease Read article

March 18, 2019 Announcement of Sweet 16 Selection for the 1st edition of Sweet Pharma Day Read article

March 18, 2019 Dr Joshua Dunaief MD, renowned AMD Clinician and Researcher, joins Mperia Therapeutics Inc. Clinical Advisory Board Read article

March 5, 2019 Announcement of the Heavyweights for the 5th edition of KNOCK OUT 2019 Read article

February 28, 2019 Mperia Therapeutics Inc. appoints Dr Christian Weber to Clinical Advisory Board Read article

February 22, 2019 Completion of a successful management buyout transaction at NuChem Therapeutics Read article